Cargando…

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valéa, Innocent, Adjei, Samuel, Usuf, Effua, Traore, Ousmane, Ansong, Daniel, Tinto, Halidou, Owusu Boateng, Harry, Leach, Amanda, Mwinessobaonfou Some, Athanase, Buabeng, Patrick, Vekemans, Johan, Nana, Louis Arnaud, Kotey, Amos, Vandoolaeghe, Pascale, Ouedraogo, Florence, Sambian, David, Lievens, Marc, Tahita, Marc Christian, Rettig, Theresa, Jongert, Erik, Lompo, Palpouguini, Idriss, Ali, Borys, Dorota, Ouedraogo, Sayouba, Prempeh, Frank, Habib, Md Ahsan, Schuerman, Lode, Sorgho, Hermann, Agbenyega, Tsiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037440/ https://www.ncbi.nlm.nih.gov/pubmed/29630438 http://dx.doi.org/10.1080/21645515.2018.1442996

Ejemplares similares

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01(E) malaria vaccine in African children: a randomized trial
por: Valéa, Innocent, et al.
Publicado: (2020)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Le vaccin antipaludique RTS,S/AS01 chez les enfants âgés de 5 à 17 mois au moment de la première vaccination
por: Vandoolaeghe, Pascale, et al.
Publicado: (2018)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
por: Tahita, Marc Christian, et al.
Publicado: (2022)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
por: Otieno, Lucas, et al.
Publicado: (2020)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
por: Guerra Mendoza, Yolanda, et al.
Publicado: (2019)

Efficacy of RTS,S/AS01(E) malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
por: Samuels, Aaron M, et al.
Publicado: (2022)

Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01(E) in Young Children
por: Olotu, Ally, et al.
Publicado: (2014)

Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso
por: Lompo, Palpouguini, et al.
Publicado: (2021)

Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso
por: Kiemde, Francois, et al.
Publicado: (2018)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

Induction of Plasmodium falciparum-Specific CD4(+) T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)
por: Agnandji, Selidji T., et al.
Publicado: (2011)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
por: White, Michael T, et al.
Publicado: (2014)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2019)

Antibiotic Susceptibility of Staphylococcus aureus and Streptococcus pneumoniae Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2021)

Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso
por: Bonko, Massa dit Achille, et al.
Publicado: (2021)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
por: White, Michael T, et al.
Publicado: (2015)

Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes
por: Miura, Kazutoyo, et al.
Publicado: (2014)

A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
por: Ndungu, Francis M., et al.
Publicado: (2012)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
por: Moris, Philippe, et al.
Publicado: (2017)

Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso
por: Brabin, Bernard, et al.
Publicado: (2019)

Diagnostic Performance of Plasmodium falciparum Histidine-Rich Protein-2 Antigen-Specific Rapid Diagnostic Test in Children at the Peripheral Health Care Level in Nanoro (Burkina Faso)
por: Bonko, Massa dit Achille, et al.
Publicado: (2022)

La Douleur Centrale Post Accident Vasculaire Cérébral au Chu Tingandogo de Ouagadougou (Burkina Faso): Fréquence, Profil Clinique, Qualité de Vie des Patients et Facteurs Associés
por: Lompo, L.D., et al.
Publicado: (2021)

Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach
por: Decuypere, Saskia, et al.
Publicado: (2016)

Correction: Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach
por: Decuypere, Saskia, et al.
Publicado: (2017)

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
por: Ajua, Anthony, et al.
Publicado: (2015)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Can clinical signs or symptoms combined with basic hematology data be used to predict the presence of bacterial infections in febrile children under - 5 years?
por: Kiemde, Francois, et al.
Publicado: (2018)

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Essential medicines wastage assessment in the Solomon Islands
por: Dadari, Ibrahim, et al.
Publicado: (2022)

Is Head and Neck Resection of the Femur (Girdlestone’s Procedure) Still Relevant? Indications and Results About 24 Cases
por: Sawadogo, Mamoudou, et al.
Publicado: (2018)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission
por: Kiemde, Francois, et al.
Publicado: (2017)

Could combined rapid diagnostic testing for malaria and c-reactive protein be helpful for the diagnosis and management of febrile illnesses in children under-5 years of age in rural Burkina Faso?
por: Bonko, Massa dit Achille, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6q11ka30k82vfihrltgtargkh